Holders over time
- LINE
- WELL
| Quarter | LINE | WELL |
|---|---|---|
| Q3 2020 | none listed holders, n.a. | 8 holders, $1.3bn |
| Q4 2020 | none listed holders, n.a. | 8 holders, $2.3bn |
| Q1 2021 | none listed holders, n.a. | 6 holders, $2.8bn |
| Q2 2021 | none listed holders, n.a. | 7 holders, $3.8bn |
| Q3 2021 | none listed holders, n.a. | 8 holders, $4.0bn |
| Q4 2021 | none listed holders, n.a. | 11 holders, $3.9bn |
| Q1 2022 | none listed holders, n.a. | 12 holders, $5.3bn |
| Q2 2022 | none listed holders, n.a. | 15 holders, $5.0bn |
| Q3 2022 | none listed holders, n.a. | 14 holders, $4.0bn |
| Q4 2022 | none listed holders, n.a. | 12 holders, $3.6bn |
| Q1 2023 | none listed holders, n.a. | 9 holders, $4.1bn |
| Q2 2023 | none listed holders, n.a. | 8 holders, $4.7bn |
| Q3 2023 | none listed holders, n.a. | 9 holders, $5.0bn |
| Q4 2023 | none listed holders, n.a. | 12 holders, $4.3bn |
| Q1 2024 | none listed holders, n.a. | 15 holders, $4.6bn |
| Q2 2024 | none listed holders, n.a. | 16 holders, $5.0bn |
| Q3 2024 | 16 holders, $1.5bn | 18 holders, $7.1bn |
| Q4 2024 | 12 holders, $1.1bn | 16 holders, $7.0bn |
| Q1 2025 | 9 holders, $1.3bn | 21 holders, $9.6bn |
| Q2 2025 | 11 holders, $1.0bn | 25 holders, $10.4bn |
| Q3 2025 | 7 holders, $646m | 22 holders, $13.2bn |
| Q4 2025 | 6 holders, $481m | 19 holders, $14.8bn |
| Q1 2026 | 4 holders, $341m | 22 holders, $18.2bn |
| Q2 2026 | 4 holders, $513m | 21 holders, $21.3bn |
Lineage Cell Theraputics In
- Holders
- 7
- Reported value
- $646m
- Buyers
- 4
- Sellers
- 4
Breadth 0 among 95 comparable managers.
Welltower Inc
- Holders
- 22
- Reported value
- $13.2bn
- Buyers
- 12
- Sellers
- 9
Breadth +3 among 95 comparable managers.
Who holds both, Q3 2025
Both (4)
Artisan Partners LP, Capital Research Global Investors, Janus Henderson Group Ltd, Schonfeld Strategic Advisors LLC
Only LINE (3)
Baillie Gifford & Co, D1 Capital Partners LP, Holocene Advisors LP
Only WELL (18)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Balyasny Asset Management LLC, Capital World Investors, D. E. Shaw & Co., Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Invesco Ltd, Marshall Wace LLP, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, T. Rowe Price Associates Inc, Two Sigma Investments LP, Wellington Management Group LLP, Woodline Partners LP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.